Block of Na+ channel by bepridil in isolated guinea-pig ventricular myocytes

European Journal of Pharmacology
N SatoK Kikuchi

Abstract

The effects of bepridil, a potent antiarrhythmic agent, on the Na+ current (INa) of single guinea-pig ventricular myocytes were studied using the whole-cell patch-clamp technique. Bepridil inhibited INa in a dose-dependent manner without causing any change in the I-V. relationship for INa. Bepridil suppressed INa with Kd values of 342 and 40 microM when cells were clamped to holding potentials of -140 and -90 mV, respectively. 10 microM bepridil shifted the steady-state inactivation curve for INa toward more negative potentials by 7.7 mV (n = 6). Bepridil also produced marked use-dependent block with a rapid onset. Recovery of INa from inactivation was retarded (time constant 290 ms) at a holding potential of -140 mV in the presence of 10 microM bepridil. When the onset of INa block was studied in experiments using a double-pulse protocol, bepridil blocked INa by 11.5% after a 4-ms pre-pulse, but significantly blocked it after pre-pulses longer than 16 ms. These results suggest that: (1) bepridil has a higher affinity for the inactivated state than the resting state of Na+ channel; (2) the drug also produces an open channel block; and (3) the drug shows a lidocaine-like fast kinetic block of Na+ current.

References

Aug 10, 1989·The New England Journal of Medicine·UNKNOWN Cardiac Arrhythmia Suppression Trial (CAST) Investigators
Oct 1, 1987·British Heart Journal·P TouboulA Dellinger
Jan 1, 1985·American Heart Journal·J SombergS Gottlieb
Mar 15, 1985·The American Journal of Cardiology·B N SinghM Schwab
Mar 15, 1985·The American Journal of Cardiology·E N Prystowsky
Mar 15, 1985·The American Journal of Cardiology·L Z Benet
Jul 1, 1981·Journal of Cardiovascular Pharmacology·E Winslow, K A Kane
Jan 1, 1980·Journal of Cardiovascular Pharmacology·K A Kane, E Winslow
May 1, 1983·The Journal of General Physiology·B P BeanR W Tsien
Jan 1, 1984·British Journal of Pharmacology·T AnnoK Yamada
Sep 1, 1983·Canadian Journal of Physiology and Pharmacology·T Li, N Sperelakis

❮ Previous
Next ❯

Citations

May 27, 2008·Circulation Journal : Official Journal of the Japanese Circulation Society·Tomomichi IshizakaAtsushi Sugiyama
Jun 5, 2001·Japanese Journal of Pharmacology·Y Watanabe, J Kimura
Aug 25, 1999·Biochemistry·S G WannerG J Kaczorowski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.